TherapeuticsMD TXMD Stock
1.99 USD
{{ price }}
-4.331728%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
22.95M USD
LOW - HIGH [24H]
1.96
-
2.08 USD
VOLUME [24H]
32K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.74 USD
TherapeuticsMD Price Chart
TherapeuticsMD TXMD Financial and Trading Overview
| TherapeuticsMD stock price | 1.99 USD |
| Previous Close | 3.78 USD |
| Open | 3.8 USD |
| Bid | 0 USD x 3000 |
| Ask | 0 USD x 1100 |
| Day's Range | 3.78 - 3.96 USD |
| 52 Week Range | 3.25 - 11.69 USD |
| Volume | 24.59K USD |
| Avg. Volume | 38K USD |
| Market Cap | 39.41M USD |
| Beta (5Y Monthly) | 1.158098 |
| PE Ratio (TTM) | 1.9296482 |
| EPS (TTM) | -0.74 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5 USD |
TXMD Valuation Measures
| Enterprise Value | 30.74M USD |
| Trailing P/E | 1.9296482 |
| Forward P/E | 10.971429 |
| PEG Ratio (5 yr expected) | -0.6 |
| Price/Sales (ttm) | 0.56553537 |
| Price/Book (mrq) | 1.1932877 |
| Enterprise Value/Revenue | 0.441 |
| Enterprise Value/EBITDA | 1.149 |
Trading Information
TherapeuticsMD Stock Price History
| Beta (5Y Monthly) | 1.158098 |
| 52-Week Change | -61.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.69 USD |
| 52 Week Low | 3.25 USD |
| 50-Day Moving Average | 3.92 USD |
| 200-Day Moving Average | 5.27 USD |
TXMD Share Statistics
| Avg. Volume (3 month) | 38K USD |
| Avg. Daily Volume (10-Days) | 35.33K USD |
| Shares Outstanding | 10.26M |
| Float | 7.67M |
| Short Ratio | 6.83 |
| % Held by Insiders | 6.37% |
| % Held by Institutions | 45.08% |
| Shares Short | 295.08K |
| Short % of Float | 3.52% |
| Short % of Shares Outstanding | 2.88% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 225.89% |
| Operating Margin (ttm) | 37.12% |
| Gross Margin | 98.99% |
| EBITDA Margin | 38.40% |
Management Effectiveness
| Return on Assets (ttm) | 16.75% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 69.68M USD |
| Revenue Per Share (ttm) | 7.48 USD |
| Quarterly Revenue Growth (yoy) | -40.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | 26.76M USD |
| Net Income Avi to Common (ttm) | 16.64M USD |
| Diluted EPS (ttm) | 1.99 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.25M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 8.58M USD |
| Total Debt/Equity (mrq) | 26.78 USD |
| Current Ratio (mrq) | 1.279 |
| Book Value Per Share (mrq) | 3.218 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7727000 USD |
| Levered Free Cash Flow (ttm) | 30.72M USD |
Profile of TherapeuticsMD
| Country | United States |
| State | FL |
| City | Boca Raton |
| Address | 951 Yamato Road |
| ZIP | 33431 |
| Phone | 561 961 1900 |
| Website | https://www.therapeuticsmd.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Q&A For TherapeuticsMD Stock
What is a current TXMD stock price?
TherapeuticsMD TXMD stock price today per share is 1.99 USD.
How to purchase TherapeuticsMD stock?
You can buy TXMD shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TherapeuticsMD?
The stock symbol or ticker of TherapeuticsMD is TXMD.
Which industry does the TherapeuticsMD company belong to?
The TherapeuticsMD industry is Drug Manufacturers-Specialty & Generic.
How many shares does TherapeuticsMD have in circulation?
The max supply of TherapeuticsMD shares is 11.53M.
What is TherapeuticsMD Price to Earnings Ratio (PE Ratio)?
TherapeuticsMD PE Ratio is now.
What was TherapeuticsMD earnings per share over the trailing 12 months (TTM)?
TherapeuticsMD EPS is -0.74 USD over the trailing 12 months.
Which sector does the TherapeuticsMD company belong to?
The TherapeuticsMD sector is Healthcare.
TherapeuticsMD TXMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}